Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.
about
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependenceMultilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDSImproving temporal efficiency of outpatient buprenorphine induction.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Emerging adult age status predicts poor buprenorphine treatment retention.Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteersNew developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent populationBaseline characteristics of patients predicting suitability for rapid naltrexone induction.The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.Comparing buprenorphine induction experience with heroin and prescription opioid users.Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.Using behavioral economics to predict opioid use during prescription opioid dependence treatment.Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.Factors associated with complicated buprenorphine inductionsA comparison of buprenorphine taper outcomes between prescription opioid and heroin usersMethadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study.Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.Does buprenorphine maintenance improve the quality of life of opioid users?Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.Retention in methadone and buprenorphine treatment among African Americans.Home buprenorphine/naloxone induction in primary careBrief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study.Community-based treatment for opioid dependent offenders: a pilot studyConfounding of the Comparative Safety of Prenatal Opioid Agonist Therapy.A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.Retention in Georgia opioid substitution therapy program and associated factors.Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories.Acupuncture-related techniques for the treatment of opiate addiction: a case of translational medicine.Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence.Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.Contingency Management interventions for non-prescribed drug use during treatment for opiate addiction: A systematic review and meta-analysis.Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge.High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment.Perceptions Related to Pharmacological Treatment of Opioid Dependence Among Individuals Seeking Treatment at a Tertiary Care Center in Northern India: A Descriptive Study.Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.
P2860
Q24200539-C10C9B60-7593-44FB-84E7-78E75765C417Q26865674-80C3F0AA-ADA7-485A-AAFB-F704CAF613F7Q28484316-C0FC7910-4084-4680-BB29-2DF5A700F6E5Q30425074-4B4BD880-04EA-4E3B-A398-38C3728E8C19Q33870389-D039347C-1605-41DA-8410-70682FEFCA3CQ34269194-12FFE198-B577-409B-971B-F17D7E0915C1Q34452695-3E547D2E-1115-4080-AE9F-D3CEE3D61D1CQ34615450-0A6A42E7-1012-4B94-B75B-286E15FAE375Q34749223-C9A5B57A-76F7-44A8-857D-45993497CD17Q34952233-EF51B28C-D9B5-42E3-86AF-4A65972124F6Q35154999-12C494C9-EDCC-4031-A22C-6E38BEEA37EBQ35834292-1817ABAF-E5B6-47DE-AC3D-ADBE10F07CBBQ35952033-D83775C0-8984-4FAC-AD4C-E5DCBDBF7C19Q35954416-C104C423-983C-4B8A-B962-068756689A0BQ36080932-1BDBEEBC-8FF0-40B0-AA72-331C38E14DA4Q36338434-6A4EC819-DD7F-4C7E-9D0E-BB17AA6060CBQ36362007-4D81409A-9F12-4D59-9845-09BD351F758DQ36585261-85A904E2-FA85-4333-B654-3F8781DF2B4CQ36595205-3EA27995-2C9B-4E59-8BE4-089986511D35Q36735035-5AF05EA7-3B28-4CA1-B8FA-AB830B67AF7EQ36800122-590FB651-000C-44E8-AE57-CFAEC8931E94Q36855559-4EBDF4AD-4560-492F-8A64-B0583D6AFAA8Q36952763-40699522-E150-4422-A28D-713ECEF5DF0EQ37022122-9E5424AF-2224-4F3A-B4A4-B39CA0834B34Q37067770-C79BC5CB-9F95-4154-AA61-E5FBDCFBCFF2Q37098791-9DD9FD7A-2EC2-4289-B42D-C02F97978540Q37107672-F57DD8B1-C7CE-4AFE-9C71-8623CC45C556Q37191073-B9497245-6B67-4DFE-81EE-B1ECAC7593A6Q37463807-53E42984-AA96-4ECD-96B1-682264DAE2B7Q37487821-0F672F74-702E-4EE1-B520-2167153E3B8DQ37661911-8AA16BB2-7A06-4499-9A15-25BA2A65918DQ37893030-D27A5AD2-C406-435A-AE4E-A2576FD81420Q38046650-75D2CADD-C192-45C8-9C01-F74C94534450Q38243268-E7648971-E2BE-4756-8056-0925DCBA8BE1Q38688566-90919F40-0FB4-4EB8-87EF-72CBC9CDAE7BQ38742135-1CA12CB7-201E-4528-AE2F-03665E88FEF3Q38981201-2DE3C00F-319F-437D-8D23-9256D5742C72Q39834450-A16B7005-5404-43C4-97EF-E5C438017EA5Q40097031-86DFB183-A2DE-416F-8BFF-389C6FD5EB17Q40142815-177A9C34-8E08-43A1-ABA8-5D017E5294D4
P2860
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Retention rate and substance u ...... sults from a randomized study.
@en
type
label
Retention rate and substance u ...... sults from a randomized study.
@en
prefLabel
Retention rate and substance u ...... sults from a randomized study.
@en
P2093
P2860
P1476
Retention rate and substance u ...... sults from a randomized study.
@en
P2093
Christina Zingg
Gabriele Koller
Heinrich Kuefner
Michael Soyka
P2860
P304
P356
10.1017/S146114570700836X
P577
2008-01-21T00:00:00Z